IT's Monday and Stock on Watch List (ATHN)

Los Angelas, CA -- (SBWIRE) -- 01/07/2013 -- Athenahealth Inc. (NASDAQ:ATHN) a Healthcare technology company said Monday that it is buying medicine-app maker Epocrates Inc. for about $292.2 million in cash in an effort to attract more physicians and offer them more services.

Under the terms of the agreement, the Watertown, Mass.-based company will pay $11.75 per share for Epocrates. That's 22 percent above the San Mateo, Calif.-based company's Friday closing stock price of $9.62. Epocrates stock jumped $2.14, or 22 percent, to $11.76 in premarket trading Monday.

Epocrates makes an app that allows doctors to look up data about medications on smartphones and tablets. Drugmakers provide most of Epocrates' revenue by buying ads within the app.

Athenahealth said buying Epocrates will boost the number of medical professionals it serves and expand its product offerings, particularly for mobile devices. Epocrates is used by about 330,000 physicians.

Athenahealth provides billing, clinical and other services to medical professionals through its online system.

Electronic medical records are designed to take the place of traditional paper records. They're designed to cut down on medical mistakes and can be shared online between medical professionals.

Epocrates shareholders representing about 17.5 percent of the outstanding common stock have agreed to vote their shares in favor of the sale, Athenahealth said. The deal, which remains subject to Epocrates shareholder and other approvals, is expected to close early in the second quarter.

Athenahealth plans to pay for it with available cash and debt.

Should Investor Invest Money In ATHN Or Wait: CLICK HERE

DISCLAIMER
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com